Why BioMarin's gene therapy initially targets one type of hemophilia instead of another
April 25, 2014 at 16:57 PM EDT
When researchers at University College London used a gene therapy to effectively cure six patients of hemophilia B, BioMarin Pharmaceutical Inc...
